Bretylium compositions and kits and their use in preventing and treating cardiovascular conditions
   
   

The present invention is directed to novel pharmaceutical combinations including compositions and kits comprising bretylium as the active ingredient, as well as methods for preventing and/or treating conditions related to the cardiovascular system using such novel pharmaceutical combinations.

 
Web www.patentalert.com

< Method of preparation of stabilized thrombin-activatable fibrinolysis inhibitor (TAFI) and methods of use thereof

< Method for identifying a test compound that modulates expression of a Fra-1 gene in a brain cancer cell

> Hydrocolloid window catheter dressing and a method for making and using the same

> Intravascular radiation delivery device
~ 00176